Basel
Switzerland
45
2019-03-14
44
2020-03-17
These are the the leading inventors for applications assigned to BASILEA PHARMACEUTICA AG:
BASILEA PHARMACEUTICA AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for the manufacture of isavuconazole or ravuconazole
#2 | 2019-01-10 ✅ Patent 10,724,072 granted on 2020-07-28Use of phospho-Akt as a biomarker of drug response
#3 | 2018-12-20 ✅ Patent 10,656,162 granted on 2020-05-19Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
#4 | 2017-11-16 ✅ Patent 10,221,206 granted on 2019-03-05Selected macrolides with PDE4-inhibiting activity
#5 | 2017-05-04 ✅ Patent 10,067,120 granted on 2018-09-04Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
#6 | 2016-11-03 ✅ Patent 9,970,938 granted on 2018-05-15Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
#7 | 2015-12-03 ✅ Patent 9,738,676 granted on 2017-08-22Selected macrolides with PDE4-inhibiting activity
#8 | 2015-08-27 ✅ Patent 9,783,508 granted on 2017-10-10Process for the manufacture of isavuconazole or ravuconazole
#9 | 2015-03-19 ✅ Patent 9,133,219 granted on 2015-09-15Bicyclic antibiotics
#10 | 2015-03-12 ✅ Patent 9,120,822 granted on 2015-09-01Tricyclic antibiotics
#11 | 2015-01-01 ✅ Patent 9,163,034 granted on 2015-10-20Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use
#12 | 2014-08-21 ✅ Patent 9,321,788 granted on 2016-04-26Tricyclic antibiotics
#13 | 2014-08-07 ✅ Patent 8,927,542 granted on 2015-01-06Bicyclic antibiotics
#14 | 2014-05-22 ✅ Patent 8,933,073 granted on 2015-01-13Macrolides and their use
#15 | 2014-03-20 ✅ Patent 10,006,078 granted on 2018-06-26Use of phospho-Akt as a biomarker of drug response
#16 | 2014-02-13 ✅ Patent 10,222,377 granted on 2019-03-05Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles
#17 | 2014-01-23 ✅ Patent 9,995,754 granted on 2018-06-12Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
#18 | 2014-01-02 ✅ Patent 9,476,889 granted on 2016-10-25Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
#19 | 2013-12-26 ✅ Patent 9,366,682 granted on 2016-06-14Use of stathmin as a biomarker of drug response to furazanobenzimidazoles
#20 | 2013-10-17 ✅ Patent 8,877,961 granted on 2014-11-04Bridged monobactam intermediates
#21 | 2013-10-17 ✅ Patent 8,809,315 granted on 2014-08-19Combination medicaments for treating bacterial infections
#22 | 2012-11-01 ✅ Patent 8,865,662 granted on 2014-10-21Macrolides and their use
#23 | 2012-10-18 ✅ Patent 8,802,858 granted on 2014-08-12Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
#24 | 2012-09-27 ✅ Patent 8,927,541 granted on 2015-01-06Tricyclic antibiotics
#25 | 2012-02-16 ✅ Patent 8,716,280 granted on 2014-05-06Bicyclic antibiotics
#26 | 2011-11-17 ✅ Patent 8,536,208 granted on 2013-09-17Antifungal composition
#27 | 2011-07-21 ✅ Patent 8,450,477 granted on 2013-05-28Process for the manufacture of bridged monobactam intermediates
#28 | 2011-06-09 ✅ Patent 8,865,697 granted on 2014-10-21Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use
#29 | 2011-03-03 ✅ Patent 8,410,065 granted on 2013-04-02Macrolides and their use
#30 | 2011-01-27 ✅ Patent 8,076,494 granted on 2011-12-13Process for the manufacture of epoxy triazole derivatives
#31 | 2011-01-27 ✅ Patent 8,445,451 granted on 2013-05-21Macrolides and uses of macrolides
#32 | 2010-06-10 ✅ Patent 8,486,929 granted on 2013-07-16Combination medicaments for treating bacterial infections
#33 | 2010-05-13 ✅ Patent 8,173,609 granted on 2012-05-08Macrolides useful against inflammatory and allergic diseases
#34 | 2010-03-04 ✅ Patent 8,901,293 granted on 2014-12-02Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
#35 | 2009-12-03 ✅ Patent 7,816,537 granted on 2010-10-19Process for the manufacture of epoxybutanol intermediates
#36 | 2009-07-30 ✅ Patent 8,093,377 granted on 2012-01-10Cephalosporin in crystalline form
#37 | 2008-09-11 ✅ Patent 8,288,421 granted on 2012-10-16Phenylaminopyridines
#38 | 2008-02-07Stabilized Freeze-Dried Formulation for Cephalosporin Derivatives
#39 | 2007-03-22 ✅ Patent 7,423,157 granted on 2008-09-09Substituted benzimidazoles and their use for inducing apoptosis
#40 | 2007-02-22 ✅ Patent 7,385,061 granted on 2008-06-10Furazanobenzimidazoles
#41 | 2007-02-01 ✅ Patent 7,459,561 granted on 2008-12-02N-substituted carbamoyloxyalkyl-azolium derivatives
#42 | 2006-11-23 ✅ Patent 7,524,823 granted on 2009-04-28Macrolides
#43 | 2006-10-03 ✅ Patent 7,115,643 granted on 2006-10-03Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
#44 | 2006-09-14 ✅ Patent 8,486,996 granted on 2013-07-16Aroylfuranes and aroylthiophenes
#45 | 2006-07-27 ✅ Patent 7,531,650 granted on 2009-05-12Cephalosporin salts in crystalline form
Also check out Basilea Pharmaceutica AG's (Basel, Switzerland) applicant profile with 16 patent applications submitted.
42765 ⎘